With a market capitalization (market cap) of $15.14B — a measure of how much the company is worth — Solventum Corporation is the 730th most valuable company in Healthcare as of August 18, 2026. Shares trade at $87.45, up +0.73% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Visit websiteAs of August 18, 2026, Solventum Corporation (SOLV) is worth $15.14B — this is its market capitalization, the total value of all its outstanding shares.
Solventum Corporation’s market cap is $15.14B, which ranks it #730 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Solventum Corporation (SOLV) shares trade at $87.45, up 0.73% on the day, as of August 18, 2026.
Solventum Corporation trades at a price-to-earnings (P/E) ratio of 9.8, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025